November 9, 2020November 9, 2020 Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications
October 30, 2020October 30, 2020 Hepatocyte Growth Factor Mimetic ANG-3777 for Cardiac Surgery–Associated Acute Kidney Injury
October 22, 2020October 22, 2020 The Effect of ANG-3777 on the Growth of c-Met Expressing Tumor Cells in Immunocompromised Mice
October 22, 2020October 22, 2020 Defining a Clinically-Meaningful Difference (MCMD) in Estimated Glomerular Filtration Rate (eGFR) for Kidney Transplantation
October 22, 2020October 22, 2020 Compartmental Differences Within the COL3A1 Network in Proteinuric Kidney Disease — Informing Drug Activity Using the Jaccard-Tanimoto Index
October 22, 2020October 22, 2020 Design of the Graft Improvement Following Transplant (GIFT) Trial, a Phase 3 Study of ANG-3777 in Kidney Transplantation Patients with Delayed Graft Function
August 4, 2020August 4, 2020 Angion Enrolls First Patients in Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia
